Supriya Lifescience Limited has informed the Exchange about Credit Rating
SUPRIYA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Supriya Lifescience has informed the stock exchange that India Ratings and Research (Ind-Ra) has assigned a credit rating to its bank loan facilities totalling Rs. 1,140 crore. The long-term rating is IND A+ with a Positive outlook, and the short-term rating is IND A1, which is the highest short-term investment grade. The rating action is listed as 'Assigned', meaning this is a fresh rating rather than an upgrade or downgrade of an existing rating. IND A+ indicates a strong capacity to meet financial commitments with low credit risk.
The Positive outlook on a strong investment-grade rating (IND A1 short-term) signals healthy creditworthiness, which should support the company's borrowing costs and access to working capital. Shareholders may view this positively as it reflects financial stability, though the rating is an 'assignment' rather than an upgrade, so there is no direct positive catalyst for the stock price.